Member Info for Tyke68

Phase 2 trial looking for about 60 patients and 32 already applied for EAP. There is a definite need and people willing to participate. You can see why the FDA seems to be holding our hands through this complex procedure.

Someone, somewhere or hopefully more than one person from a big pharma must have us on their radar. The question is will they make a bid before we start phase 2 otherwise a successful phase 2 would increase our valuation exponentially and that doesn’t take into account the imaging size. Anything with AI in the title seems to generating interest at the moment.

Focus on the future we can’t change what has happened in the past with the “shenanigans”. If you can afford it consider it an opportunity.

Thanks

Bamb

I think we all think it will eventually be taken over but the issue is for what price?

Thanks

A great update that shows the progress the company is making not only on the drug trial but the imaging side. Well done to all those involved.

32 patients interested in the EAP will definitely give real world data that hopefully expedites the approval process and shows the need for this to succeed. Fingers crossed it helps these patients.

Time for the market to catch up with all the great things happening with this company.

Thanks

Better watch these rounded buys before results. They maybe Smantic’s institutional friends

Thanks

Gee

Totally agree

“ More than 45 different hospitals and healthcare systems are at varying stages of evaluating our software, with more sites entering the sales pipeline. This step-change in pre-sales activity is approximately a seven-fold increase over previous periods and is due, in large part, to the traction gained from our platform partners including TeraRecon (Eureka) and Bayer (Calantic). These partners have the medical expertise and marketing reach to sell our technologies into large existing installed customer bases and have ample sales and marketing resources to win clients.

It is a relatively easy up-sell for IB's partners' sales teams to activate IB's technology on platforms already being used clinically. The number of sites evaluating our software continues to increase. Thus, we are optimistic about the revenue activity and anticipate a step-change starting in the 2nd half of 2023.”

I don’t think there can be any excuses if the sales haven’t increased substantially. An update on the insurance payment code would be good as well. Get the imaging side profitable and contribute towards the cost of the drugs trial

Thanks

Will we get any RNSs this week before the half year results? Has TB got any surprises, hopefully positive ones, to keep shareholders happy. How many of the sales leads have been turned into actual sales, we keep being lead to believe a step change in sales is due plus a positive update on the phase 1 and the EAP would be good.

Fingers crossed

Thanks

Thanks Max back in UK now.

Jen C really seems to be at the front of a lot of things we are doing. Needs a lot of praise in my opinion.

Thanks

Max

I have just been through hurricane Debby so no more stormy waters for me please. I have never seen sidewards rain before. I wouldn’t mind being very new money or idle rich. However, for that to happen hopefully a lot of people will get a drug that really helps them and I would like that to happen as well.

Thanks

We should get the interims next week or week after. I am surprised no positive RNSs in the build up

Thanks

Have a good weekend everybody especially semantic

Thanks

Semantic

In your opinion do you think treatment for a higher grade tumour would imply a higher valuation if and a big if our trial was successful? Hopefully the data from the people already signed up for the EAP will help.

Thanks

$1.1 billion sounds a nice amount

$5 a share, I could buy a Porsche with that.

Thanks

Cautious

Thanks still no Porsche

Still may happen

Thanks

Semantic

Thank you. I agree we shareholders should now be looking at least 2 years plus and let the IB team carry on with all their work. I know I for one got caught up thinking about the PRV being imminent but I think the company fed into that hype and didn’t fully explain the time frames. I know we don’t know what is happening behind the scenes but maybe that is something the BoD could look into improving upon whilst letting Mike and the team carry on with all the research etc. Anyway thank you for the informative post.

Thanks

Dear Semantic

When you first started posting here it was after some shareholders voted against TB etc being reappointed, you implied people should concentrate on the future and you wanted to discuss that. However, since then whenever I have asked you your thoughts about things eg could they sell the imaging or drug side separately you have ignored the questions.

So in my mind:

•you never really wanted to discuss the future of the company but wanted to share cryptic posts with a bit of Latin thrown in to cause disruption on this board and have now started to belittle genuine shareholders in the company

Or

* you are an insider and know answering direct questions on the future of the company isn’t allowed. In which case belittling shareholders is not a very good look.

Either way or possibly another option your comments are becoming less relevant as the personal attacks increase. Either actively discuss the company or maybe try causing discontent on another of TB’s company’s bulletin boards. The majority of posters on here want the company to succeed for both patient wellbeing and financial gain for ourselves and at least we are being honest about it and we try to be polite and civilised in our discussions.

Thanks

I never knew semantic modelled himself on Gordon Gecko. Wasn’t that film about certain people being greedy, unscrupulous and just looking out for themselves?

Oh well I will stick with my morals and manners. Is semantic trying to imply something may drop Monday and I don’t mean the share price?

Have a good week everybody or am I not allowed to say that anymore?

Thanks

Have a good weekend everybody

Thanks

A plan to help increase the share price as alluded to previously by the BoD that they would be trying to achieve would be nice to know.

Thanks

Fiduciary responsibility to ALL shareholders springs to mind.

Thanks

Since semantic implied an institutional investor was sniffing around on Monday we have traded 500k shares. Either the smallest institution ever reminiscent of “the bank of Ant and Dec” adverts or semantic was trying to create a bit trade in the company himself by spreading rumours.

Anyway, have a good weekend everybody, you never know next week could be even quieter.

Thanks